CLINICAL TRIAL OPTIMIZATION Trademark

Trademark Overview

On Wednesday, January 12, 2011, a trademark application was filed for CLINICAL TRIAL OPTIMIZATION with the United States Patent and Trademark Office. The USPTO has given the CLINICAL TRIAL OPTIMIZATION trademark a serial number of 85215913. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 17, 2023. This trademark is owned by Covance Inc.. The CLINICAL TRIAL OPTIMIZATION trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Conducting clinical trials of pharmaceuticals and medical devices; scientific research services, namely, tracking, analyzing, forecasting, and reporting data in the field of clinical trials of pharmaceuticals and medical devices
clinical trial optimization

General Information

Serial Number85215913
Word MarkCLINICAL TRIAL OPTIMIZATION
Filing DateWednesday, January 12, 2011
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 17, 2023
Registration Number4203797
Registration DateTuesday, September 4, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Disclaimer with Predetermined Text"CLINICAL TRIAL"
Goods and ServicesConducting clinical trials of pharmaceuticals and medical devices; scientific research services, namely, tracking, analyzing, forecasting, and reporting data in the field of clinical trials of pharmaceuticals and medical devices

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 17, 2023
Primary Code042
First Use Anywhere DateTuesday, March 1, 2011
First Use In Commerce DateTuesday, March 1, 2011

Trademark Owner History

Party NameLABCORP DRUG DEVELOPMENT INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressPRINCETON, NJ 085406233
Party NameCovance Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 085406233
Party NameCovance Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 085406233

Trademark Events

Event DateEvent Description
Friday, March 17, 2023CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Wednesday, September 7, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Saturday, September 4, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, September 4, 2018NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Tuesday, September 4, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED
Tuesday, September 4, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, August 31, 2018TEAS SECTION 8 RECEIVED
Monday, September 4, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, September 4, 2012REGISTERED-SUPPLEMENTAL REGISTER
Wednesday, August 1, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, July 31, 2012APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Wednesday, July 11, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 11, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 13, 2012TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, June 5, 2012NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, June 5, 2012FINAL REFUSAL E-MAILED
Tuesday, June 5, 2012FINAL REFUSAL WRITTEN
Tuesday, May 1, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 1, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 1, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, November 6, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, November 6, 2011NON-FINAL ACTION E-MAILED
Sunday, November 6, 2011NON-FINAL ACTION WRITTEN
Wednesday, October 12, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 12, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 12, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 25, 2011NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Tuesday, May 24, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 24, 2011NON-FINAL ACTION E-MAILED
Tuesday, May 24, 2011USE AMENDMENT ACCEPTED
Tuesday, May 24, 2011NON-FINAL ACTION WRITTEN
Wednesday, April 27, 2011AMENDMENT TO USE PROCESSING COMPLETE
Wednesday, April 27, 2011USE AMENDMENT FILED
Tuesday, April 26, 2011TEAS AMENDMENT OF USE RECEIVED
Tuesday, April 26, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 12, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 12, 2011NON-FINAL ACTION E-MAILED
Tuesday, April 12, 2011NON-FINAL ACTION WRITTEN
Thursday, March 31, 2011ASSIGNED TO EXAMINER
Wednesday, February 9, 2011PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Friday, February 4, 2011ASSIGNED TO LIE
Thursday, January 27, 2011TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, January 18, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 15, 2011NEW APPLICATION ENTERED

Related Keywords

optimization trial clinical devices pharmaceuticals medical trials forecasting reporting field analyzing data